depression
DEPRESSION

Depression is a mood disorder wherein the patient have a pervasive sad mood or loss of interest in most activities for at least 2 weeks.

It can cause significant distress & impairment. It is also a chronic, episodic and relapsing syndrome.

Treatment can either be by psychotherapy alone or pharmacotherapy alone or psychotherapy combined with pharmacological therapy.

Diagnosis

Perform Thorough Diagnostic Evaluation

  • Determine if other psychiatric or general medical conditions are present
  • Should include but is not limited to:
    • Physical exam
    • Mental status exam
    • History of past and current illnesses
    • History of suicidal thoughts and suicide attempts
    • General medical history
    • Psychiatric history
      • To include symptoms of mania because presence of manic symptoms would prompt that the patient be diagnosed with bipolar disorder
    • Family history of psychiatric disorders
    • Substance abuse history
    • Medication review
    • Mental status evaluation
    • Diagnostic tests as indicated
      • Screening tools eg Patient Health Questionnaire (PHQ9), PHQ2 or Two-Question Screen, Beck Depression Inventory for Primary care
    • Evaluation of functional impairment
    • Evaluation of life events and stressors

Evaluation

Diagnostic Criteria

  • Based on DSM-5 diagnostic criteria, major depressive disorder is diagnosed when 5 or more of the following symptoms that causes change or distress in previous functioning have been present during the same 2 week (and at least one of the symptoms is either depressed mood or lack of interest or pleasure):
    • Depressed mood in adults or irritable mood in children that either self-reported or observable most of the day, nearly every day
    • Lack or diminished interest or pleasure in almost all activities most of the time, nearly every day
    • Significant weight loss when not dieting, weight gain or appetite disturbance in adults. While in children, this can be failure to attain expected weight gain
    • Sleep disturbance that can be insomnia or hypersomnia nearly every day
    • Psychomotor agitation or retardation
    • Feeling of fatigue or lack of energy nearly every day
    • Sense of diminished/lost of self-worth or inappropriate guilt nearly every day
    • Inability to concentrate and there is indecisiveness
    • Frequent thoughts of death, could be of suicidal attempts, with or without specific plan
  • The symptoms should not be a physiological effect of any substance as well as any general medical condition
  • The disorder occurrence is not due to schizoaffective disorder, schizophrenia, delusional disorder, or other specified or unspecified schizophrenia spectrum and other psychotic disorders
  • Manic and hypomanic episodes have not occurred
  • Distinguishing between normal sadness and grief from major depressive disorder is important
    • Bereavement induces great suffering but does not typically induces major depressive disorder
    • When bereavement and major depressive disorder concurrently exist, the latter has more severe symptoms and functional impairment and worse prognosis compared to bereavement alone
    • Diagnosis of major depressive disorder in a patient who had significant loss would need clinical judgment based on the patient’s history and cultural context for expression of grief
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 3 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 4 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.